Danazol mediates collateral sensitivity via STAT3/Myc related pathway in multidrug-resistant cancer cells
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-019-48169-2.pdf
Reference39 articles.
1. Gottesman, M. M. Mechanisms of cancer drug resistance. Annual review of medicine 53, 615–627, https://doi.org/10.1146/annurev.med.53.082901.103929 (2002).
2. Szakacs, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C. & Gottesman, M. M. Targeting multidrug resistance in cancer. Nature reviews. Drug discovery 5, 219–234, https://doi.org/10.1038/nrd1984 (2006).
3. Chen, Z. et al. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer letters 370, 153–164, https://doi.org/10.1016/j.canlet.2015.10.010 (2016).
4. Kathawala, R. J., Gupta, P., Ashby, C. R. Jr. & Chen, Z. S. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy 18, 1–17, https://doi.org/10.1016/j.drup.2014.11.002 (2015).
5. Szakacs, G. et al. Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance. Chemical reviews 114, 5753–5774, https://doi.org/10.1021/cr4006236 (2014).
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. SUMO E3 ligase MUL1 inhibits lymph node metastasis of bladder cancer by mediating mitochondrial HSPA9 translocation;International Journal of Biological Sciences;2024
2. MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products;Aging and disease;2024
3. Novel (-)-arctigenin derivatives inhibit signal transducer and activator of transcription 3 phosphorylation and P-glycoprotein function resensitizing multidrug resistant cancer cells in vitro and in vivo;European Journal of Pharmacology;2023-12
4. Research progress of small-molecule drugs in targeting telomerase in human cancer and aging;Chemico-Biological Interactions;2023-09
5. Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system;Cancer Drug Resistance;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3